CORRECTION article

Front. Immunol., 04 October 2021

Sec. Viral Immunology

Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.779064

Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients

  • 1. The Wistar Institute, Philadelphia, PA, United States

  • 2. The Burnet Institute, Melbourne, VIC, Australia

  • 3. Department of Infectious Diseases, Monash University, Melbourne, VIC, Australia

  • 4. Rush Center for Integrated Microbiome and Chronobiology Research, Rush University, Chicago, IL, United States

  • 5. Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States

In the original article, there was a typo in Figure 1E, Supplementary Figure 3, and Supplementary Table 10 as published. The unit of the β-glucan should have been (pg/ml) instead of (ng/ml). The corrected Figure 1, Supplementary Figure 3, and Supplementary Table 10 appear below.

Figure 1

The authors apologize for this error and state that this does not change any of the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2021.779064/full#supplementary-material

Summary

Keywords

SARS-CoV-2, COVID-19, microbial translocation, inflammation, zonulin, metabolomics, glycomics, lipidomics

Citation

Giron LB, Dweep H, Yin X, Wang H, Damra M, Goldman AR, Gorman N, Palmer CS, Tang H-Y, Shaikh MW, Forsyth CB, Balk RA, Zilberstein NF, Liu Q, Kossenkov A, Keshavarzian A, Landay A and Abdel-Mohsen M (2021) Corrigendum: Plasma Markers of Disrupted Gut Permeability in Severe COVID-19 Patients. Front. Immunol. 12:779064. doi: 10.3389/fimmu.2021.779064

Received

17 September 2021

Accepted

21 September 2021

Published

04 October 2021

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2021

Updates

Copyright

*Correspondence: Mohamed Abdel-Mohsen,

This article was submitted to Viral Immunology, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics